TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive In Brief: Nobel Laurate Joshua Lederberg to Replace Schmidt As President’s Cancer Panel Chairman June 1, 1979
TCL Archive Black Men Face Disparate Cancer Burden; Minority Rates Vary, Klausner Tells House April 3, 1998